Verdegem P, Freed S, Joffe D. The Clinical Impact of Fiber Supplementation on Cardio-Vascular Risk Parameters in type-2 Diabetes in 6th International Conference on Atherosclerosis, Thrombosis and Vascular Biology. 2005. Washinton, DC, USA. The American Heart Association sent out a press release on the study results.
Verdegem P, Duenas V, Duenas J, Burke E. LDL- and HLD-cholesterol optimization using phytonutrient combination therapy: first line intervention and adjunct therapy to statins in 1st Asian Preventive Cardiology & Cardiac Rehabilitation Conference. 2006. Hong Kong. 7th International Congress on Coronary Artery Disease, 2007, Venice, Italy.
Freed S, Joffe D (2004) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes II Diabetes in Control 212, 17, and Verdegem P, Freed S, Joffe D (2005) The clinical impact of fiber supplementation for the reduction of postprandial blood blucose and reduction of complications from type-2 diabetes Diabetes 54, A425.
Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction: Farida Jeejeebhoy, MD, Mary Keith, PhD, Michael Freeman, MD, Aiala Barr, PhD, Michele McCall, MSc, RD, Regina Kurian, BSc, David Mazer, MD, and Lee Errett, MD, Am Heart J 2002;143:1092-100. (the product MyoVive is marketed by our previous parent company and has the same ingredients as Cardio Essentials)
Effect of a Cetylated Fatty Acid Topical Cream on Functional Mobility and Quality of Life of Patients with Osteoarthritis William J. Kraemer, Nicholas A. Ratamess, Jeffrey M. Anderson, Carl M. Maresh, David P. Tiberio, Michael E. Joyce, Barry N. Messinger, Duncan N. French, Matthew J. Sharman, Martyn R. Rubin, Aan L. Gomez, Jeff S. Volek, and Robert L. Hesslink Jr., J Rheumatol 2004;31:767–74